Barings’s Prestige Consumer Healthcare PBH Stock Holding History

Barings’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,849	Closed	-$269K	–	878
2016 Q2	$269K	Hold	4,849	–	–	0.01%	811
2016 Q1	$259K	Hold	4,849	–	–	0.01%	840
2015 Q4	$250K	Hold	4,849	–	–	0.01%	815
2015 Q3	$219K	Buy	+4,849	New	+$229K	0.01%	833

Other funds holding PBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Barings's PBH Position: Q3 2016 in Review

Barings sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 4,849 shares — an estimated $269K sold.

Barings first reported a position in PBH in Q3 2015 and held it in 4 quarters. The position peaked at $269K in Q2 2016. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

Barings reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
Barings sold 4,849 Prestige Consumer Healthcare shares in Q3 2016, an estimated $269K.
Barings first reported a position in Prestige Consumer Healthcare in Q3 2015 and held it in 4 quarters.
Barings's Prestige Consumer Healthcare position peaked at $269K in Q2 2016.
243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Barings's 13F filing for Q3 2016, filed 14 Nov 2016.